Vaginal Hysterectomy with Salpingectomy for Essure Insert Removal.


Journal

Journal of minimally invasive gynecology
ISSN: 1553-4669
Titre abrégé: J Minim Invasive Gynecol
Pays: United States
ID NLM: 101235322

Informations de publication

Date de publication:
Historique:
received: 29 05 2018
revised: 18 07 2018
accepted: 23 07 2018
pubmed: 5 8 2018
medline: 7 8 2019
entrez: 5 8 2018
Statut: ppublish

Résumé

To evaluate the feasibility of an en-bloc salpingectomy at the time of vaginal hysterectomy for removal of Essure inserts. Prospective observational study (Canadian Task Force classification II-1). Monocenter study at the Conception University Hospital Center, Marseille, France. Women seeking removal of the Essure device and candidate for vaginal hysterectomy from January 1, 2017 to January 31, 2018. Patient underwent a total hysterectomy and bilateral salpingectomy by the vaginal route (VH-S) with en-bloc removal of each hemiuterus with the ipsilateral fallopian tube, thereby allowing for removal of the Essure inserts without fragmentation. Twenty-six VH-S were performed. There was no converted case to laparoscopy or laparotomy because of issues regarding feasibility or complications. Removal of each hemiuterus with the ipsilateral tube as a single unit was feasible in all cases. There was 1 Clavien-Dindo grade 1 perioperative complication: a bladder injury that required 10days of urinary catheterization. There were 2 grade 2 postoperative complications: 1 case of metrorrhagia of a granuloma on the vaginal fundus that was treated with silver nitrate and 1 case of acute urinary retention that required urinary catheterization for 24hours. Performing a VH-S with en-bloc removal of the hemiuterus with the ipsilateral tube without fragmentation orsectioning of the Essure inserts appears to be feasible. The vaginal route can hence be an approach for women who undergo hysterectomy during Essure insert surgery removal.

Identifiants

pubmed: 30077005
pii: S1553-4650(18)30370-4
doi: 10.1016/j.jmig.2018.07.019
pii:
doi:

Types de publication

Journal Article Observational Study Research Support, Non-U.S. Gov't

Langues

eng

Pagination

695-701

Informations de copyright

Copyright © 2018 AAGL. Published by Elsevier Inc. All rights reserved.

Auteurs

Axelle Charavil (A)

Department of Obstetrics and Gynecology, La Conception Hospital, Aix Marseille University, Marseille, France (Drs. Charavil, Agostini, Rambeaud, Schmitt, and Tourette).

Aubert Agostini (A)

Department of Obstetrics and Gynecology, La Conception Hospital, Aix Marseille University, Marseille, France (Drs. Charavil, Agostini, Rambeaud, Schmitt, and Tourette). Electronic address: aubert.agostini@ap-hm.fr.

Caroline Rambeaud (C)

Department of Obstetrics and Gynecology, La Conception Hospital, Aix Marseille University, Marseille, France (Drs. Charavil, Agostini, Rambeaud, Schmitt, and Tourette).

Andy Schmitt (A)

Department of Obstetrics and Gynecology, La Conception Hospital, Aix Marseille University, Marseille, France (Drs. Charavil, Agostini, Rambeaud, Schmitt, and Tourette).

Claire Tourette (C)

Department of Obstetrics and Gynecology, La Conception Hospital, Aix Marseille University, Marseille, France (Drs. Charavil, Agostini, Rambeaud, Schmitt, and Tourette).

Patrice Crochet (P)

Department of Obstetrics and Gynecology, Arnaud de Villeneuve Hospital, University of Montpellier, Montpellier, France (Dr. Crochet).

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH